Portman Square Capital’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-71,200
Closed -$8.42M 244
2024
Q4
$8.42M Sell
71,200
-8,600
-11% -$1M 0.3% 81
2024
Q3
$8.82M Hold
79,800
0.33% 98
2024
Q2
$7.85M Hold
79,800
0.27% 113
2024
Q1
$8.93M Sell
79,800
-86,300
-52% -$9.31M 0.25% 111
2023
Q4
$16.7M Sell
166,100
-80,000
-33% -$7.94M 0.38% 68
2023
Q3
$21.4M Buy
246,100
+150,800
+158% +$13.6M 0.53% 50
2023
Q2
$9.01M Buy
+95,300
New +$8.05M 0.26% 101

Other funds holding CAH

Portman Square Capital's CAH Position: Q3 2024 in Review

Portman Square Capital sold out of Cardinal Health (CAH) in Q3 2024, closing a stake of 7,371 shares — an estimated $771K sold.

Portman Square Capital first reported a position in CAH in Q3 2023 and held it in 3 quarters. The position peaked at $2.95M in Q3 2023. 1,015 funds tracked by Wall St. Rank hold CAH as of Q3 2024.

  • Portman Square Capital reported no remaining Cardinal Health position as of Q3 2024 after selling out during the quarter.
  • Portman Square Capital sold 7,371 Cardinal Health shares in Q3 2024, an estimated $771K.
  • Portman Square Capital first reported a position in Cardinal Health in Q3 2023 and held it in 3 quarters.
  • Portman Square Capital's Cardinal Health position peaked at $2.95M in Q3 2023.
  • 1,015 funds tracked by Wall St. Rank held Cardinal Health as of Q3 2024.

Based on Portman Square Capital's 13F filing for Q3 2024, filed 16 Oct 2024.